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in long-term aorta related morbidity and mortality. These ﬁndings may have
implications on risk stratiﬁcation, frequency of surveillance imaging, and future
treatments.
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Covered Endovascular Reconstruction of Aortic Bifurcation or CERAB-
technique for treating extensive aortoiliac occlusive disease.
Peter Goverde1, Michel Reijnen2
1ZNA Stuivenberg Hospital, Antwerp, Belgium, 2Rijnstate Hospital, Arhnem,
Netherlands
Background: We developed the Covered Endovascular Reconstruction of Aortic
Bifurcation or CERAB-technique for extensive and/or recurrent aortoiliac occlusive
disease using V12 covered balloon expandable stents (Atrium Maquet Getinge Europe
BV) to rebuild the aortic bifurcation.
Methods: Endovascular bifemoral recanalisation of the aortoiliac axes,; placement
and expansion of a 12 mm V12 Large Diameter in the distal aorta (9 Fr). Pick up of
the already expanded V12 stent with an large balloon (adapted to the aortic diameter).
The balloon is so positioned that the distal marker is about 15 mm proximal to the
distal stent margin. After positioning and expansion, the distal stent part becomes
funnel-shaped. Two iliac covered stent-grafts are then placed in this segment, in
a "kissing-stent" conﬁguration and inﬂated. Both stents are now making a very tight
combination with the aortic stent, as were they moulded together, simulating a new
bifurcation
Results: Two-centre prospective, non-randomised, follow-up study. We treated now
70 patients with acute, chronic or recurrent aortoiliac occlusive disease. Technical
success rate up till now was almost 95%. Follow-up 52 – 1 months. 5 patients died of
non-interventional causes . Five patients re-occluded, mainly due to progressive distal
peripheral disease. They received successfully thrombolysis and treatment of the
outﬂow problems. The other patients showed no complications.
Conclusions: Covered Endovascular Reconstruction of Aortic Bifurcation or
CERAB is safe and feasible and can be performed completely percutaneous. A
larger population, longer follow-up, further haemodynamic investigation is needed
Distal peripheral outﬂow needs to be sufﬁcient enough. It can be combined as
a "hybrid" procedure. CERAB can be used for the treatment of recurrent or in-stent
disease It is even feasible to treat lesion that extend to the iuxta and/or supral renal
aortic region
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The Potential Role of Statin in Patients with Critical Limb Ischemia.
Atsushi Tosaka1, Yoshimitsu Soga2, Osamu Iida3, Masato Nakamura4
1Kawakita General Hospital, Tokyo, Tokyo, 2Kokura Memorial Hospital, Kitakyushu,
Japan, 3Kansai Rosai Hospital, Amagasaki, Hyogo, 4Toho University Ohashi Medical
Center, Tokyo, Japan
Background: Revascularization is the optimal treatment to avoid major amputation
for critical limb ischemia (CLI) patients. Although previous studies report that statin
administration is associated with a reduced risk for cardiovascular events, the efﬁcacy
for CLI patients is unclear. In this study, we aimed to compare the outcomes in CLI
patients with statin administration and without statin administration after endovascular
therapy (EVT).
Methods: This study is a subanalysis from Endovascular Treatment for Infra-inguinal
Vessel, in patients with critical limb ischemia, - A Prospective, Multi-center, 12 month
follow-up Registry in Japan: Olive Registry. From November 2009 to December
2011, a total of 310 patients with CLI who underwent EVT for infrainguinal artery
disease were enrolled. The outcome measures were limb salvage and major adverse
limb event (MALE). MALE was deﬁned as major amputation or major reintervention
including surgical procedure.
Results: The mean follow-up period was 294  138 days. Sixty-ﬁve percent were
male, 26% had statin administration. Rutherford class IV was found in 38 patients, V
in 217 patients and VI in 55 patients. Kaplan-Meier survival curve showed that the
limb salvage rate at one year was 97.3% in the statin group, 89.7% in the without
statin group (P¼0.03). In adjusted model, limb salvage rate and freedom from MALE
were statistically higher in the statin group (P<0.01).
Conclusions: Statin administration after infrainguinal angioplasty for CLI patients
improved limb salvage rate and freedom from MALE.B164 JACC Vol 62/18/Suppl B j October 27–NTCT-545
The AURORAA registry : 1 year reults using interwoven nitinol stents for
extensive distal femoropopliteal occlusive disease.
Peter Goverde1, Katrien Lauwers2, Sven Vercauteren2
1ZNA Stuivenberg Hospital, Antwerp, Belgium, 2Vascular Clinic ZNA, Antwerp,
Belgium
Background: In the endovascular treatment of extensive disease in the distal super-
ﬁcial femoral and popliteal level, you can encounter ﬂow limiting problems, where
stent placement is needed after balloon angioplasty. At the moment most of the
standard bare nitinol stents will have difﬁculties in these areas. With the introduction
of the Supera stent (IDEV Technologies, Inc., Texas, US) we may have an answer in
treating those problematic lesions
Methods: Because of the Superas new design; with 6 interwoven nitinol wires, it has
extraordinary characteristics : very ﬂexible, kink, fracture and crush resistant together
with great radial force. We have treated more than 100 patients with extensive distal
femoropopliteal disease (TASC II C & D) with heavy calciﬁcations, occlusions,
recurrent disease, stent fractures etc. These lesions, that not responded to balloon
angioplasty and that needed stent placement, were al treated with placement of Supera
stents.
Results: Results of the single centre prospective AURORAA registry : Follow up
done by ultrasound. Five patients died of non-interventional causes.. Six months
primary patency was more then 90%. Twelve months primary patency was around
81%. We observed further more no stent fractures or ﬂow limiting kinking in this very
difﬁcult "to stent" area (distal superﬁcial femoral artery & popliteal artery). Average
lesion length: 14 cm; average stent length : 18 cm. Technical success rate :96 %
Conclusions: The Supera stent can be a solution when the use of a "classic" nitinol
stent is not indicated or favourable , especially in the femoropoliteal area. It has very
good patency rates, despite the very difﬁcult region to treat This self expandable stent
system can be a necessary complement in your tool box due to its special
characteristics
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Safety and feasibility of one day discharge after endovascular revascularization
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Antonio, TX, 5San Antonio Endovascular & Heart Institute, San Antonio, TX,
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Background: The elderly have a high prevalence of peripheral arterial disease (PAD)
and it seems that they may be less suitable for a one day discharge after endovascular
revascularization (ER) mainly due to a higher ratio in hemorrhage complications.
Therefore we sought to evaluate whether the advantages of one day discharge after ER
on lower extremities can be safely extended for the elderly.
Methods: Between January 2008 and June 2012, 455 ER were performed on lower
extremities with Bivalirudin as an anticoagulant. The decision of deployment the
vascular closure device (VCD) was left to the operator discretion. Patients 70 years old
and older were included to the study group (n¼235). The rest of the patients created
the control group (n¼220). The follow up was done at 24 hours and 30 days afterovember 1, 2013 j TCT Abstracts/POSTER/Endovascular Intervention
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hematoma were considered the composite endpoint of major vascular complications
(MVC). Secondary endpoints were: death, stroke, myocardial infarction, amputation
and target lesion revascularization (TLR).
Results: The study cohort had average age of 79 (range 70- 95) years compared to
60.9 in the control group (range 38- 69). Study group were more likely to be female,
but less likely to be current smokers, diabetic and dialysis reliant (p < 0.001). There
were no differences between groups in VCD deployment and critical limb ischemia.
The mean time to ambulation in the elderly and control group were 3.6 hours (1.2)
and 3.4 hours (1.3) respectively (p¼ 0.8). In 24 hours as well as in 30 days follow up
there were no signiﬁcant differences in the primary and secondary endpoints between
groups. Current smoking status (OR¼2.35, 95% CI: 0.485- 11.46) in the octogenar-
ians, whereas female sex (OR¼ 1.75, 95% CI: 0.389- 7.86) and hypercholesterolemia
(OR¼ 6.739, 95% CI: 0.294- 154.4) in controls were found to be independent
predictors of MVC at 30 days.
Conclusions: The same day discharge after ER on lower extremities is safe and
feasible in the elderly.
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Long term outcomes of percutaneous lower- extremity arterial interventions with
balloon angioplasty versus atherectomy- propensity score matched registry.
Adam Janas1, Krzysztof P. Milewski2, Piotr P. Buszman3, Ksenia Kosteczko4,
Magda Konkolewska5, Radoslaw Szymanski2, Buszman E. Pawel6, R. Stefan Kiesz7
1Center of Cardiovascular Research and Development American Heart Of Polnad,
Katowice, Silesia, 2American Heart of Poland, Katowice, Silesia, 3American Heart of
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Background: The atherosclerosis plaques have different morphology from soft
neointimal plaques to hard calciﬁed lesions. Therefore, we sought to evaluate the
efﬁcacy of percutaneous balloon angioplasty (PTA) versus atherectomy (AT) endo-
vascular revascularization which type was attuned by operator.
Methods: Between 2008 and 2013 a total of 419 endovascular revascularizations were
performed on arteries of lower extremities. In this registry we include patients with
claudication as well as with critical limb ischemia (CLI). The endpoints were
considered as target lesion revascularization (TLR), amputation, major adverse
cardiovascular event (MACE) and bailout stenting (BS). MACE was deﬁned as death,
myocardial infarction and stroke. The type of atherectomy (excisional- soft plaque,
orbital- calciﬁed plaque, with active aspiration- with a thrombus) was left to the
operator's discretion
Results: The PTA was performed on 215 patients, whereas AT was used in 204 cases
(Silver Hawk TM, EV3- MN, USA -125; CSI360 MN, USA- 66 Pathway Medical
Technologies- 13). The mean follow up time was 500 (454) days. There were no
signiﬁcant differences in baseline characteristics between groups with the exception of
increased coronary artery disease, dialysis and CLI for PTA group. There were
signiﬁcant differences in TVR (PTA: 32% vs. AT: 21%; p¼0.01), death (PTA8% vs.
AT: 2%; p¼0.009) and BS (PTA:9% vs. AT:1% p<0.001). Kaplan- Mayer analysis
showed no signiﬁcant differences between groups in time to TLR, amputation, death.
After adjustment this was sustained.
Conclusions: In this observational analysis, atherectomy endovascular revasculari-
zation offered better long term outcomes than balloon angioplasty.
TCT-548
Variability in Analysis of Freedom from Primary Patency from Trials Assessing
Stent Implantation in the Superﬁcial Femoral Artery.
Moshe Vardi1, Lanyu Lei1, Gheorghe Doros2
1Harvard Clinical Research Institute, Boston, MA, 2Bston University, Boston, MA
Background: Primary Patency (PP) in trials assessing Superﬁcial Femoral Artery
(SFA) stenting is deﬁned as a combination of vessel patency assessed by Duplex
ultrasound (DUS) at 12 month visit and freedom from revascularization of the index
vessel through 12 month follow-up. Patients are thus more likely to lose PP during the
mandated DUS assessment. Moreover, DUS is performed within a pre-speciﬁed
window which exceeds 12 months, thus the time frame for analyzing patency via DUS
exceeds the time frame by which revascularization is captured. There are no guidelines
as to the correct method for presenting these analysis in reports from clinical trials. We
aimed to analyze the implications of applying different methods in assessing freedom
from loss of PP in studies assessing stenting for SFA disease.
Methods: We simulated a dataset of patients and outcomes based on existing
available results from SFA stenting trials. Six different approaches to Kaplan Meier
(KM) analyses were applied based on entry criteria into and time frame of the KM
model.
Results: Six KM estimates of freedom from loss of PP were generated for each of the
10,000 simulation sets. The six different methods averaged from 67.9% to 81.8%.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: Survival analyses of freedom from loss of PP vary substantially
according to the methods employed. These may lead to misrepresentation of results
from clinical trials. The development of a uniﬁed approach is advocated.
TCT-549
Sub-analysis of the CONFIRM Registries: Outcomes in Claudicant Patients
Treated for Peripheral Arterial Disease with Orbital Atherectomy
George Adams1, Jeffrey Indes2, Jihad A. Mustapha3, Robert W. Vorhies4
1Rex Healthcare, University of North Carolina, Raleigh, NC, 2Yale University School
of Medicine, New Haven, CT, 3Metro Health Hospital, Grand Rapids, MI, 4Cox
Health, Springﬁeld, MO
Background: Intermittent claudication affects 2.5% of women and 5% of men over
the age of 60. Advanced age, diabetes, and renal insufﬁciency predispose patients to
intra-arterial calcium which is a predictor of poor endovascular treatment success.
Methods of treating peripheral arterial disease (PAD) have evolved and now include
minimally-invasive endovascular procedures, utilizing orbital atherectomy (OA)
which can modify calciﬁc plaque both above and below-the-knee.
Methods: Three consecutive CONFIRM patient registries were conducted prospec-
tively and enrolled patients on an "all comers" basis to evaluate the use of orbital
atherectomy in peripheral lesions of the lower extremities. Analysis of all 3135
patients enrolled in the CONFIRM I-III registries revealed 1698 patients with clau-
dication (Rutherford Class 1-3) and documented lesion morphology. We analyzed the
CONFIRM series to compare procedural complications after OA treatment of lesions
with moderate/severe calcium versus lesions without moderate/severe calcium in
claudicant patients.
Results: Eighty-two percent of claudicants treated with OA had moderate/severely
calciﬁed lesions. There was no signiﬁcant difference in the percentage of perforations
(0.6% vs 0%), slow ﬂow (2.9% vs 2.6%), closure (1.4% vs 2.3%), spasm (3.8% vs
6.3%), embolism (1.7% vs 2.6%), or thrombus (1.1% vs 1.3%), in claudicants with
moderate/severely calciﬁed lesions vs without moderate/severely calciﬁed lesions,
respectively. Claudicants with moderate/severe calcium had fewer dissections than
those without moderate/severely calciﬁed lesions (10.9% vs 16.2%, p¼0.004).
Conclusions: The majority of the claudicant patients in this study had lesions with
moderate to severe calciﬁcation, yet the occurrence of adverse events was low after
treatment with orbital atherectomy. Orbital atherectomy is a safe tool for restoring
blood ﬂow in the lower extremities of claudicant patients regardless of arterial calcium
burden.
TCT-550
Assessment of Stability and Bactericidal Activity of a Novel Triple Antimicrobial-
Bonded Graft for Preventing Perioperative Aortic Infection
Ibrahim Aboshady1, Issam Raad2, Kamal G. Khalil3, L. Maximilian Buja3
1Texas Heart Institute, Houston, TX, 2MD Anderson Cancer Center, Houston, TX,
3The University of Texas HSC, Houston, TX
Background: Prosthetic aortic grafts remain problematic despite enhancements in
biomaterials and production prosthetics, improved surgical techniques, and a better
understanding of the pathogenesis of graft infections. Previously, we investigated
a locally developed technique of bonding aortic grafts with 3 antimicrobials to prevent
early (within 2 weeks) direct perioperative bacterial contamination related to aortic
graft operations. In the current phase, we attempted to determine whether the
concentrations of the antimicrobials bonded to the graft are sufﬁcient to prevent
postoperative aortic graft infections for a longer period (8 weeks).
Methods: Nine Sinclair miniature pigs received a 6-mm vascular Dacron graft in the
infrarenal portion of the abdominal aorta. Six pigs received grafts chemically bonded
with 60-mg/mL solutions of rifampin, minocycline, and chlorhexidine; 3 pigs received
unbonded grafts. Before implantation, the 6 bonded grafts and 2 of the unbonded
grafts were immersed for 15 minutes in a 2-mL bacterial solution containing 1 to
2107 colony-forming units (CFUs)/mL of Staphylococcus aureus (ATCC 29213);
the 3rd unbonded graft served as a control. The pigs were observed for 8 weeks after
graft implantation; then the pigs were sacriﬁced, and the grafts were excised. Beforeacts/POSTER/Endovascular Intervention B165
